ES2180923T3 - Proceso para la preparacion de derivados de purina. - Google Patents

Proceso para la preparacion de derivados de purina.

Info

Publication number
ES2180923T3
ES2180923T3 ES97901569T ES97901569T ES2180923T3 ES 2180923 T3 ES2180923 T3 ES 2180923T3 ES 97901569 T ES97901569 T ES 97901569T ES 97901569 T ES97901569 T ES 97901569T ES 2180923 T3 ES2180923 T3 ES 2180923T3
Authority
ES
Spain
Prior art keywords
preparation
purine derivatives
intermediates
purin
propanediol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97901569T
Other languages
English (en)
Other versions
ES2180923T5 (es
Inventor
Humberto B Arzeno
Steven D Axt
Colin C Beard
Charles A Dvorak
Paul R Fatheree
Lawrence E Fisher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES2180923T3 publication Critical patent/ES2180923T3/es
Application granted granted Critical
Publication of ES2180923T5 publication Critical patent/ES2180923T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA INVENCION SE REFIERE A UN PROCEDIMIENTO Y A NUEVOS INTERMEDIARIOS PARA LA PREPARACION DE UN ESTER DE L - MONOVALINA DE 2 - (2 - AMINO - 1,6 - DIHIDRO - 6 - OXO - PURIN - 9 IL)METOXI - 1, 3 - PROPANODIOL Y DE SUS SALES FARMACEUTICAMENTE ACEPTABLES. EL PRESENTE PROCEDIMIENTO E INTERMEDIARIOS PRODUCE UNA REDUCCION DE IMPUREZAS EN EL PRODUCTO FINAL DE ESTER DE MONO VALINA, ELIMINANDO ASIMISMO LA FASE DE PURIFICACION, COSTOSA Y LENTA, PERMITIENDO LA UTILIZACION DE MATERIALES DE PARTIDA DE PUREZA INFERIOR, LO CUAL, CONSECUENTEMENTE, REDUCE LOS COSTES TOTALES DE PRODUCCION. DICHOS PRODUCTOS SON VALIOSOS COMO AGENTES ANTIVIRALES DE ABSORCION MEJORADA.
ES97901569T 1996-01-26 1997-01-21 Proceso para la preparacion de derivados de purina. Expired - Lifetime ES2180923T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59207996A 1996-01-26 1996-01-26
US592079 1996-01-26

Publications (2)

Publication Number Publication Date
ES2180923T3 true ES2180923T3 (es) 2003-02-16
ES2180923T5 ES2180923T5 (es) 2005-10-16

Family

ID=24369197

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97901569T Expired - Lifetime ES2180923T5 (es) 1996-01-26 1997-01-21 Proceso para la preparacion de derivados de purina.

Country Status (10)

Country Link
JP (1) JP4094667B2 (es)
KR (1) KR100491941B1 (es)
CN (1) CN1064683C (es)
AT (1) ATE222909T1 (es)
AU (1) AU1543797A (es)
CA (1) CA2243650C (es)
DE (1) DE69714971T3 (es)
ES (1) ES2180923T5 (es)
MX (1) MX9805935A (es)
WO (1) WO1997027198A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5869493A (en) * 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
WO2005023827A1 (en) * 2003-09-11 2005-03-17 F. Hoffmann-La Roche Ag Process for preparing antiviral nucleoside derivatives
ZA200702234B (en) * 2006-03-21 2008-07-30 Cipla Ltd Preparation of ester of purine derivatives
CN103562207B (zh) * 2011-05-31 2016-08-17 法尔玛赞公司 用于制备缬更昔洛韦的2-氨基-9-((2-苯基-1，3-二噁烷-5-基氧基)甲基)-1h-嘌呤-6(9h)-酮化合物的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816447A (en) * 1981-08-26 1989-03-28 Merck & Co., Inc. Anti-viral guanine compounds
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
AP55A (en) * 1987-08-15 1989-09-26 The Wellcome Foundation Ltd Therapeutic Acyclic Nucleosides
CA2005815C (en) * 1988-12-19 1999-08-03 Wellcome Foundation Limited (The) Antiviral acyclic nucleoside derivatives
JP3225545B2 (ja) * 1991-09-18 2001-11-05 味の素株式会社 非環状ヌクレオシド類の製造法
PE32296A1 (es) * 1994-07-28 1996-08-07 Hoffmann La Roche Ester de l-monovalina derivado de 2-(2-amino-1,6-dihidro-6-oxo-purin-9-il) metoxi-1,3-propandiol y sus sales farmaceuticamente aceptables

Also Published As

Publication number Publication date
JP4094667B2 (ja) 2008-06-04
JP2000503977A (ja) 2000-04-04
ATE222909T1 (de) 2002-09-15
KR100491941B1 (ko) 2005-08-05
DE69714971D1 (de) 2002-10-02
AU1543797A (en) 1997-08-20
CA2243650A1 (en) 1997-07-31
DE69714971T2 (de) 2003-05-28
CA2243650C (en) 2006-08-15
WO1997027198A1 (en) 1997-07-31
CN1064683C (zh) 2001-04-18
DE69714971T3 (de) 2005-12-15
CN1212693A (zh) 1999-03-31
KR19990081991A (ko) 1999-11-15
MX9805935A (es) 1998-11-30
ES2180923T5 (es) 2005-10-16

Similar Documents

Publication Publication Date Title
ES2138648T3 (es) Derivados de 1h-indol-3-acetamidas como inhibidores de spla2.
MY114393A (en) 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1, 3-propanediol derivatives
BR9205286A (pt) Processo para purificar solucao de etanol bruta aquosa
FI96030B (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen tetraliinien, kromaanien ja niitä läheisesti muistuttavien yhdisteiden valmistamiseksi sekä menetelmässä käyttökelpoisia välituotteita
FI931332A7 (fi) Uusia alkyleenidiammoniumdiklavulanaattijohdannaisia, menetelmä niidenvalmistamiseksi samoin kuin niiden käyttö kalvulaanihapon puhdistamiseksi
HUT42078A (en) Process for preparing benzoxazine derivatives applicable in the production of herbicides as intermediates
AU1543797A (en) Process for preparing purine derivatives
ES2118870T3 (es) Procedimiento para la purificacion de acido clavulanico en bruto.
FI891004A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 4-substituoitujen pyratsolo/3,4-d/pyrimidiinijohdannaisten valmistamiseksi
DE3485419D1 (de) Glyzerinderivate.
IL138288A0 (en) Process for the production of purine derivatives and intermediates thereof
PT91093A (pt) Processo para a preparacao de derivados de acido 2,6-diclorodifenilamino- -acetico
MX26167A (es) Derivados de acido piridil-benzoico para el tratamiento de enfermedades relacionadas con lecotrino.
BR9002997A (pt) Processo para producao de ester metilico de alfa-i-aspartil-i-fenilalanina cristalino,facilmente soluvel
PT88116A (pt) Process for preparing naphthalenepropionic acid derivatives useful as anti-inflammatory/antiallergic agents
BR9202335A (pt) Processo para a preparacao de alcano-sulfanomidas
EP1000933A4 (en) TRIFLUORO METHYLTHIOMETHYL BENZENE DERIVATIVES AND PROCESS FOR PRODUCING THE SAME
DE69111640D1 (de) 7-(Diphenylmethyl)oxy-9a-methoxymitosan, seine Herstellung und Verwendung.
BR9800281A (pt) Processos para preparação de cloro-benzoilcloretos, e de derivados de benzofenona cloro-substiˆtuìda
BR0317029A (pt) Processo para a preparação de compostos peptìdicos bicìclicos
HUT34460A (en) Process for preparing formyl derivative of 2-amino-n-/1h-tetrazol-5-y1/-benzamide
JPS5334743A (en) Preparation of 2-(4-alkylphenyl)propionic acids
PT97320A (pt) Processo para a preparacao de derivados do acido 6-fluor-1,4-dihidro-4-oxo-7-piperazinil-quinolinocarboxilico
EP0439129A3 (en) Optically active isoxazole derivatives and intermediates for preparation thereof as well as processes for producing the same
CA2232913A1 (en) Process for the preparation of azide derivatives